Studies: BEP ± darbepoetin

ID Trial

AH 09/03

Description

BEP ± darbepoetin

Status

closed

Stages

Stage  
metastatic good prognosis
metastatic intermediate prognosis

Treatment arms

No data

Trial characteristics

Trial type

Chemotherapie
supportive Therapie

Objectives

Objektive Ansprechrate (OR)
Gesamtüberleben (OS)
progressionsfreies Überleben (TTP)
Transfusionshäufigkeit

Disease characteristics

diagnosis confirmed by histology tumor measurable in two dimensions

Treatment characteristics

No data

Patient characteristics

Age between 18 and 70 years
Sex male
ECOG ≤ 2
no uncontrolled infections
no second cancers

Hematology

Leucocytes ≥ 1500/µl
Thrombocytes ≥ 75.000/µl

Liver functon

Bilirubin bis 1,5x normal

Renal function

Creatinine bis 1,25x normal

Coordinating investigator

Prof. Dr. P. Albers
Universitätsklinikum Düsseldorf
Urologische Klinik
Moorenstr. 5
40225 Düsseldorf
 Prof. Dr. C. Bokemeyer
Universitätsklinikum Hamburg-Eppendorf
II. Medizinische Klinik und Poliklinik
Martinistr. 52
20246 Hamburg

Principal investigator

Dr. V. Grünwald
Medizinische Hochschule Hannover
Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation
Carl-Neuberg-Str. 1
30625 Hannover